Concepedia

Fuqiang Ban

FB

Statistics

Publications

59

Citations

4.2K

H-Index

33

Active since

1999

Affiliations

University of British Columbia(Current)

Dalhousie University

Simon Fraser University

The Prostate Centre

Princess Margaret Cancer Centre

Fuqiang Ban is an author at University of British Columbia specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1999–2024

59

Publications

59

Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds

Anh‐Tien Ton, Francesco Gentile, Michael Hsing et al. · Molecular Informatics · 2020 · 518 citations · Full text

, , +15

SimBoost: a read-across approach for predicting drug–target binding affinities using gradient boosting machines

Tong He, Marten Heidemeyer, Fuqiang Ban et al. · Journal of Cheminformatics · 2017 · 509 citations · Full text

, , +15

Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery

Francesco Gentile, Vibudh Agrawal, Michael Hsing et al. · ACS Central Science · 2020 · 425 citations · Full text

, , +17

Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site

Jaeyong Lee, L.J. Worrall, M. Vuckovic et al. · Nature Communications · 2020 · 232 citations · Full text

, , +17

The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-(((<i>cis</i>)-2,6-Dimethylmorpholino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent

Peter B. Sampson, Yong Liu, Bryan Forrest et al. · Journal of Medicinal Chemistry · 2014 · 171 citations · Full text

, , +10

1–5 of 59